FDA Authorizes New Two-Minute Serological Test Kit to Detect Novel Coronavirus | Business Wire

FDA Authorizes New Two-Minute Serological Test Kit to Detect Novel Coronavirus | Business Wire
LOS ANGELES--(BUSINESS WIRE)--BODYSPHERE Inc., announced today they are distributing a new Two-Minute Testing Kit for the diagnosis of the novel coronavirus (COVID-19). The U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization for the test which uses antibodies in blood to test for current or past infection. The tests have a 91% clinical specificity rate and a 99% clinical sensitivity rate. Results are delivered on site in as fast as two minutes. This is a game changer as today in the United States, most COVID-19 testing results take between two to seven days